This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrough so advanced, it’s going to make ChatGPT look like VHS. But what’s even more unbelievable? I believe it’ll make Nvidia’s meteoric rise look like a backyard bottle rocket.

Click here and I’ll tell you everything you need to know.

Paul Horstmeier Biography and Net Worth

COO of Health Catalyst

Mr. Horstmeier brings 25 years of Fortune 500 and small business operations and general management experience to Health Catalyst. He co-founded HB Ventures and filled senior executive roles at HB Ventures portfolio companies. Within Hewlett-Packard, Mr. Horstmeier launched and grew three different businesses, including co-founding HP’s commercial e-commerce business which later expanded to include the management of the data systems and infrastructure for marketing operations across the company. As Vice President of HP.com, Paul headed up a 700-person organization which was awarded nearly every industry award for quality and innovation during his tenure.

Mr. Horstmeier holds an MBA and a BS in Computer Science from BYU.

What is Paul Horstmeier's net worth?: The estimated net worth of Paul Horstmeier is at least $1.33 million as of April 12th, 2022. Mr. Horstmeier owns 180,316 shares of Health Catalyst stock worth more than $1,327,126 as of November 20th. This net worth estimate does not reflect any other investments that Mr. Horstmeier may own. Learn More about Paul Horstmeier's net worth.
How do I contact Paul Horstmeier?: The corporate mailing address for Mr. Horstmeier and other Health Catalyst executives is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. Health Catalyst can also be reached via phone at (801) 708-6800 and via email at [email protected]. Learn More on Paul Horstmeier's contact information.
Has Paul Horstmeier been buying or selling shares of Health Catalyst?: Paul Horstmeier has not been actively trading shares of Health Catalyst over the course of the past ninety days. Most recently, Paul Horstmeier sold 5,208 shares of the business's stock in a transaction on Tuesday, April 12th. The shares were sold at an average price of $25.16, for a transaction totalling $131,033.28. Following the completion of the sale, the chief operating officer now directly owns 180,316 shares of the company's stock, valued at $4,536,750.56. Learn More on Paul Horstmeier's trading history.
Who are Health Catalyst's active insiders?: Health Catalyst's insider roster includes Jason Alger (CAO), Daniel Burton (CEO), Bryan Hinton (CTO), Paul Horstmeier (COO), Bryan Hunt (CFO), Linda Llewelyn (Insider), James Nelli, Jr. (President), Daniel Orenstein (CEO), and Anita Pramoda (Director). Learn More on Health Catalyst's active insiders.
Are insiders buying or selling shares of Health Catalyst?: During the last year, insiders at the sold shares 16 times. They sold a total of 56,514 shares worth more than $416,355.35. The most recent insider tranaction occured on November, 5th when COO Daniel Lesueur sold 5,209 shares worth more than $40,109.30. Insiders at Health Catalyst own 2.5% of the company. Learn More about insider trades at Health Catalyst.
Information on this page was last updated on 11/5/2024.

Paul Horstmeier Insider Trading History at Health Catalyst

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/12/2022	Sell	5,208	$25.16	$131,033.28	180,316
3/9/2022	Sell	23,209	$25.30	$587,187.70
2/7/2022	Sell	10,750	$29.10	$312,825.00
1/5/2022	Sell	10,750	$36.78	$395,385.00
12/6/2021	Sell	6,063	$39.20	$237,669.60
11/5/2021	Sell	10,750	$51.97	$558,677.50
10/5/2021	Sell	10,750	$48.09	$516,967.50
9/7/2021	Sell	8,598	$54.90	$472,030.20	117,039
8/5/2021	Sell	10,750	$55.80	$599,850.00	123,879
7/6/2021	Sell	10,750	$57.01	$612,857.50	123,879
6/7/2021	Sell	8,635	$55.38	$478,206.30	121,764
5/5/2021	Sell	9,836	$54.94	$540,389.84	127,652
4/5/2021	Sell	5,800	$48.09	$278,922.00	118,902
2/1/2021	Sell	10,750	$49.44	$531,480.00	83,440
12/1/2020	Sell	10,750	$35.00	$376,250.00	92,004
10/1/2020	Sell	10,750	$36.42	$391,515.00	92,004
9/1/2020	Sell	10,750	$31.65	$340,237.50	92,004
8/3/2020	Sell	10,800	$35.51	$383,508.00	92,054
7/1/2020	Sell	10,750	$28.93	$310,997.50	81,004
6/1/2020	Sell	10,750	$26.97	$289,927.50	80,500
5/1/2020	Sell	10,750	$25.39	$272,942.50	85,750
4/1/2020	Sell	10,750	$26.65	$286,487.50	85,750
3/3/2020	Sell	10,750	$28.53	$306,697.50	85,750

Paul Horstmeier Buying and Selling Activity at Health Catalyst

Health Catalyst Company Overview

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Today's Range

Now: $7.36

$7.20

$7.50

50 Day Range

MA: $8.14

$7.36

$8.86

2 Week Range

Now: $7.36

$5.42

$11.41

Volume

472,361 shs

Average Volume

520,549 shs

Market Capitalization

$447.86 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.32

Missed Nvidia? Watch this ASAP

From Brownstone Research | Ad